Abstract
Background
Sentinel lymph node biopsy (SLNB) is an important treatment option for breast cancer patients, as it can accurately predict axillary status. Our previous study using dye with or without radioisotope showed the accuracy and sensitivity of SLNB to be 97% and 94%, respectively. Based on these results, axillary lymph node dissection (ALND) was eliminated starting in January, 1999 in patients with intraoperatively negative SLNB at our institution. The present study shows the results and outcomes of SLNB as a sole procedure for patients with invasive breast cancer.
Patients and Methods
Three-hundred-fifty-four patients and 358 cases of invasive breast cancer (4 bilateral breast carcinoma) treated with SLNB alone after an intraoperative negative SLNB were studied prospectively from January 1999 to December 2001.
Results
The number of the identified SLNs per case ranged from 1 to 8 (mean, 2.5). Of a total of 358 cases, 297 (83%) were treated with hormone therapy and/or chemotherapy, and 281 (78%) were treated with radiotherapy to the conserved breast (50 Gy ± 10 Gy boost), the axilla (50 Gy), or the both sites. After a median follow-up of 21 (range 6–42) months, no patient developed an axillary relapse. Four cases initially recurred in distant organs and one case in the conserved breast.
Conclusions
Our results indicate that an intraoperative negative SLNB without further ALND may be a safe procedure when strict SLNB is performed. To better assess the safety, however, may require longer follow-up.
Similar content being viewed by others
Abbreviations
- SLNB:
-
Sentinel lymph node biopsy
- ALND:
-
Axillary lymph node dissection
- UFT:
-
Tegafur and uracil
- NSABP:
-
National Surgical Adjuvant Breast and Bowel Project
- ACOSOG:
-
American College of Surgeons Oncology Group
References
Halstead WS: The results of radical operations for the cure of carcinoma of the breast.Ann Surg 46: 1–19 1907.
Veronesi U and Valagussa P: Inefficacy of internal mammary node dissection in breast cancer surgeryCancer 47: 170–175, 1981.
Nieweg OE, Tanis PJ, Kroon BBR,et al: The defini tion of a sentinel node.Ann Surg Oncol 8: 538–541 2001.
Morton DL, Wen DR, Wong JH,et al: Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 127: 392–399, 1992.
Krag DN, Weaver DL, Alex JC,et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2: 335–340, 1993.
Giuliano AE, Kirgan DM, Guenther JM,et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 220: 391–401, 1994.
Cody HS III: Sentinel lymph node mapping in breast cancer.Breast Cancer 6: 13–22, 1999.
Kusawake T, Suemasu K, Sugamata T,et al: A new breast cancer surgery: Less invasive surgery for node-negative patients by sentinel lymph node biopsy.J Jpn Coll Surg 26: 163–166, 2001 (in Japanese).
Noguchi M: Sentinel lymph node biopsy in breast cancer: an overview of the Japanese experience.Breast Cancer 8: 184–193, 2001.
Morrow M: Management of the axillary nodes.Breast Cancer 6: 1–12, 1999.
Ross MI: Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA.Ann Surg Oncol 8: 77–81, 2001.
Noguchi M, Tsugawa K, Miwa K,et al: Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization.Breast Cancer 7: 287–296, 2000.
Schwartz GF, Giuliano AE, Veronesi U, the Consensus Conference Committee: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania.Cancer 94: 2542–2551, 2002.
Veronesi U, Galimberti V, Zurrida S,et al: Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer.Eur J Cancer 37: 454–458, 2001.
Giuliano AE, Haigh PI, Brennan MB,et al: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.J Clin Oncol 18: 2553–2559, 2000.
Roumen RMH, Kuijt GP, Liem IH,et al: Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.Br J Surg 88: 1639–1643, 2001.
Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A,et al: Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection.J Surg Oncol 77: 165–170, 2001.
Fisher B, Redmond C, Fisher ER,et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.N Engl J Med 312: 674–681, 1985.
Hoebers FJP, Borger JH, Hart AAM,et al: Primary axillary radiotherapy as axillary treatment in breastconserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.Cancer 88: 1633–1642, 2000.
Johansen H, Kaae S, and Schiodt T: Simple mastectomy with postoperative irradiation versus extended radical mastectomy in breast cancer. A twenty-five-year follow-up of a randomized trial.Acta Oncol 29: 709–715, 1990.
Author information
Authors and Affiliations
Corresponding author
Additional information
Reprint requests to Hiroyuki Takei, Division of Breast Surgery, Saitama Cancer Center, 818 Ina-machi, Kitaadachi, Saitama 362-0806, Japan.
About this article
Cite this article
Takei, H., Suemasu, K., Kurosumi, M. et al. Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. Breast Cancer 9, 344–348 (2002). https://doi.org/10.1007/BF02967615
Issue Date:
DOI: https://doi.org/10.1007/BF02967615